ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

“Long Overdue” Efforts By States Urged To Help Fund Community, Regional Cancer Control Efforts

August 4, 1978

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004

In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1

July 15, 1983

Moses, Earp to lead AACI. Funding opportunities.

September 12, 2003

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000